Pfizer Inc.'s banner

Pfizer Inc.

@pfizer_news • 33,812 subscribers

The official X channel dedicated to media and communications from Pfizer. To see all of our posts, please follow @pfizer.

Shorts

Pfizer’s treatment for #hemophilia A & B received U.S. FDA approval for two new patient populations, meeting a significant medical need and offering the first subcutaneous non-factor therapy for children ages 6-11 years old with hemophilia B with inhibitors. Learn more:

Pfizer’s treatment for #hemophilia A & B received U.S. FDA approval for two new patient populations, meeting a significant medical need and offering the first subcutaneous non-factor therapy for children ages 6-11 years old with hemophilia B with inhibitors. Learn more:

31,303 views